Hyman Charles D cut its position in shares of Colgate-Palmolive Company (NYSE:CL) by 2.6% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 68,437 shares of the company’s stock after selling 1,862 shares during the period. Hyman Charles D’s holdings in Colgate-Palmolive were worth $5,009,000 as of its most recent SEC filing.

Other large investors have also added to or reduced their stakes in the company. Swiss National Bank boosted its stake in Colgate-Palmolive by 22.2% in the first quarter. Swiss National Bank now owns 3,667,072 shares of the company’s stock worth $268,393,000 after buying an additional 666,400 shares during the period. Karp Capital Management Corp boosted its stake in Colgate-Palmolive by 3,749.4% in the first quarter. Karp Capital Management Corp now owns 381,210 shares of the company’s stock worth $27,901,000 after buying an additional 371,307 shares during the period. UBS Asset Management Americas Inc. boosted its stake in Colgate-Palmolive by 11.1% in the first quarter. UBS Asset Management Americas Inc. now owns 2,532,717 shares of the company’s stock worth $185,370,000 after buying an additional 253,665 shares during the period. Delta Lloyd NV boosted its stake in Colgate-Palmolive by 388.5% in the first quarter. Delta Lloyd NV now owns 311,123 shares of the company’s stock worth $22,413,000 after buying an additional 247,438 shares during the period. Finally, State of Wisconsin Investment Board boosted its stake in Colgate-Palmolive by 42.6% in the first quarter. State of Wisconsin Investment Board now owns 772,063 shares of the company’s stock worth $56,507,000 after buying an additional 230,564 shares during the period. Institutional investors own 73.15% of the company’s stock.

Colgate-Palmolive Company (CL) traded down 0.65% during mid-day trading on Wednesday, reaching $70.84. The company had a trading volume of 660,431 shares. The company has a market capitalization of $62.40 billion, a price-to-earnings ratio of 26.32 and a beta of 0.80. Colgate-Palmolive Company has a 12 month low of $63.43 and a 12 month high of $77.27. The firm’s 50 day moving average price is $71.99 and its 200-day moving average price is $73.12.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Friday, July 21st. The company reported $0.72 earnings per share for the quarter, meeting the Zacks’ consensus estimate of $0.72. The company had revenue of $3.83 billion for the quarter, compared to analysts’ expectations of $3.89 billion. Colgate-Palmolive had a return on equity of 3,121.95% and a net margin of 15.83%. The business’s revenue for the quarter was down .5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.70 earnings per share. Equities research analysts anticipate that Colgate-Palmolive Company will post $2.89 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which was paid on Tuesday, August 15th. Stockholders of record on Tuesday, July 18th were issued a dividend of $0.40 per share. The ex-dividend date was Friday, July 14th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.24%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 59.48%.

WARNING: This piece of content was originally reported by Watch List News and is the sole property of of Watch List News. If you are reading this piece of content on another site, it was illegally stolen and republished in violation of US and international copyright legislation. The correct version of this piece of content can be read at https://www.watchlistnews.com/colgate-palmolive-company-cl-shares-sold-by-hyman-charles-d/1532162.html.

A number of equities research analysts have commented on CL shares. Zacks Investment Research cut Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Wednesday, May 3rd. Jefferies Group LLC reiterated a “hold” rating and issued a $76.00 price target on shares of Colgate-Palmolive in a research note on Wednesday, May 17th. Bank of America Corporation increased their price target on Colgate-Palmolive from $78.00 to $80.00 and gave the company a “buy” rating in a research note on Wednesday, May 31st. BidaskClub cut Colgate-Palmolive from a “sell” rating to a “strong sell” rating in a research note on Wednesday, July 12th. Finally, Vetr cut Colgate-Palmolive from a “buy” rating to a “hold” rating and set a $76.67 price target for the company. in a research note on Wednesday, May 17th. Two investment analysts have rated the stock with a sell rating, twelve have assigned a hold rating and two have issued a buy rating to the company. The stock has an average rating of “Hold” and a consensus target price of $75.82.

In other news, insider Patricia Verduin sold 3,833 shares of Colgate-Palmolive stock in a transaction that occurred on Monday, July 17th. The stock was sold at an average price of $72.41, for a total transaction of $277,547.53. Following the sale, the insider now owns 53,022 shares of the company’s stock, valued at $3,839,323.02. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, COO Justin Skala sold 74,374 shares of Colgate-Palmolive stock in a transaction that occurred on Thursday, July 27th. The shares were sold at an average price of $72.51, for a total value of $5,392,858.74. Following the sale, the chief operating officer now directly owns 97,177 shares in the company, valued at approximately $7,046,304.27. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 221,802 shares of company stock worth $15,983,976. Corporate insiders own 1.02% of the company’s stock.

About Colgate-Palmolive

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with Analyst Ratings Network's FREE daily email newsletter.